Evaluations of Bayesian and maximum likelihood methods in PK models with below-quantification-limit data

Pharmaceutical Statistics

Volumn 9, Issue 4, 2010, Pages 313-330

  Yang, Shuying ^a   Roger, James ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bayesian method; BQL; censored data; maximum likelihood; population pharmacokinetics model

Indexed keywords

ARTICLE; BAYES THEOREM; LIMIT OF QUANTITATION; MONTE CARLO METHOD; PARAMETER; PHARMACOKINETICS; SIMULATION; STATISTICAL ANALYSIS;

BAYES THEOREM; MODELS, BIOLOGICAL; PHARMACOKINETICS;

EID: 78650684954     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.400     Document Type: Article

References (18)

1. Beal SL,. Ways to fit a PK model with some data below the quantification limit. Journal of Pharmacokinetics and Pharmacodynamics 2001; 28: 481-504.
2. Hing JP, Woolfrey SG, Greenslade D, Wright PMC,. Analysis of toxicokinetic data using NONMEM: impact of quantification limit and replacement strategies for censored data. Journal of Pharmacokinetics and Pharmacodynamics 2001; 28: 465-479.
3. Rahman N, Wakefield JC, Stephens DA, Falcoz C,. The Bayesian analysis of a pivotal pharmacokinetic study; Statistical Methods in Medical Research 1998; 8: 195-216.
4. Beal SL, Sheiner LB, Boeckmann AJ, (eds). NONMEM Users Guides. Icon development solutions: Ellicott City; 1989-2006.
5. Bergstrand M, Plan E, Kjellsson MC, Karlsson KO,. A comparison of methods for handling of data below the limit of quantification in NONMEM VI. PAGE 16. 2007; Abstract 1201
6. Ahn JE, Karlsson MO, Dunne A, Ludden TM,. Likelihood based approaches to handling data below the quantification limit using NONMEM VI. Journal of Pharmacokinetics and Pharmacodynamics 2008; 35: 401-421.
7. Spiegelhalter D, Thomas A, Best N,. WinBUGS user manual, 2003. Available at:.
8. Tod M,. Handling concentrations below quantification limit in population. PAGE 11. 2002; Abstract 252
9. Dartois C, Looby M, He H, Steimer J-L, Pillai G., Impact of handling missing PK data on PD estimation-explicit modeling of BLQ data in WinBUGS® reduced bias in the PD predictions-a preclinical example. PAGE 16. 2007; Abstract 1101
10. SAS institute Inc. SAS manual. SAS institute Inc: Cary, NC, 2002-2004.
11. Lunn DJ, Best N, Thomas A, Wakefield J, Spiegelhalter D,. Bayesian analysis of population PK/PD models: general concepts and software. Journal of Pharmacokinetics and Pharmacodynamics 2002; 29: 271-307.
12. Byon W, Fletcher CV, Brundage RC,. Impact of censoring data below an arbitrary quantification limit on structural model misspecification. Journal of Pharmacokinetics and Pharmacodynamics 2008; 35: 101-116.
13. Boeckmann AJ, Beal SL, Sheiner LB,. NONMEM Users Guide Part VII (conditional estimation methods). NONMEM Project Group: San Francisco; 1992.
14. Wang Y,. Derivation of various NONMEM estimation methods. Journal of Pharmacokinetics and Pharmacodynamics 2007; 34: 575-593.
15. Gelman A,. Prior distributions for variance parameters in hierarchical models. Bayesian Analysis 2006; 1: 515-533.
16. Bennett JE, Wakefield JC,. A comparison of a Bayesian population method with two methods as implemented in commercially available software. Journal of Pharmacokinetics and Biopharmaceutics 1996; 24: 403-432.
17. Duval V, Karlsson MO,. Impact of omission or replacement of data below the limit of quantification on parameter estimates in a two-compartment model. Pharmaceutical Research 2002; 19: 1835-1840.
18. Rabe-Hesketh S, Skrondal A, Pickles A,. Reliable estimation of generalized linear mixed models using adaptive quadrature. The Stata Journal 2002; 2: 1-21.